Response to comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".

Autor: Ganesan G; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Ponniah S; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Sundaram V; Sundaram Hospital, Trichy, India., Marimuthu PK; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Pitchaikannu V; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Chandrasekaran M; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Thangarasu J; RPS Hospitals, Chennai, India., Kannupaiyan G; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Ramamoorthy P; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Thangaraj B; Harshamitra Super-Specialty Cancer Centre and Research Institute, India., Vaishnavi RS; Harshamitra Super-Specialty Cancer Centre and Research Institute, India.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Feb; Vol. 167, pp. 325. Date of Electronic Publication: 2021 Dec 08.